Ortataxel Completed Phase 2 Trials for Glioblastomas Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01989884An Efficacy Study Of Ortataxel In Recurrent Glioblastoma